By altering transcription baselines, this tripeptide serves as a vital tool for studying cell migration, angiogenesis, and the regulation of inflammatory cascades
Available at: [accessed March 2026]. Once-weekly semaglutide in adults with overweight or obesity (STEP 1) structured abstract and commentary
GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) work by reducing appetite, increasing satiety, and slowing gastric emptying to achieve weight loss
This expansion followed the SELECT (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity) trial, which demonstrated cardiovascular benefit among adults with overweight/obesity and without diabetes
Available evidence strongly suggests the opposite, that tirzepatide is actively supporting kidney health through multiple pathways including reduced inflammation, improved metabolic function, and decreased albuminuria